View in EDS PDF Full Text

Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs.

Saved in:
Bibliographic Details
Title: Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs.
Authors: Kavanaugh A; A. Kavanaugh, MD, University of California San Diego, La Jolla, California, USA; akavanaugh@ucsd.edu., Westhovens RR; R.R. Westhovens, MD, PhD, KU Leuven, Skeletal Biology and Engineering Research Center, Leuven, Belgium., Winthrop KL; K.L. Winthrop, MD, MPH, Oregon Health and Science University, Portland, Oregon, USA., Lee SJ; S.J. Lee, MD, Y. Tan, PhD, D. An, PhD, L. Ye, PhD, J.S. Sundy, MD, PhD, Gilead Sciences Inc., Foster City, California, USA., Tan Y; S.J. Lee, MD, Y. Tan, PhD, D. An, PhD, L. Ye, PhD, J.S. Sundy, MD, PhD, Gilead Sciences Inc., Foster City, California, USA., An D; S.J. Lee, MD, Y. Tan, PhD, D. An, PhD, L. Ye, PhD, J.S. Sundy, MD, PhD, Gilead Sciences Inc., Foster City, California, USA., Ye L; S.J. Lee, MD, Y. Tan, PhD, D. An, PhD, L. Ye, PhD, J.S. Sundy, MD, PhD, Gilead Sciences Inc., Foster City, California, USA., Sundy JS; S.J. Lee, MD, Y. Tan, PhD, D. An, PhD, L. Ye, PhD, J.S. Sundy, MD, PhD, Gilead Sciences Inc., Foster City, California, USA., Besuyen R; R. Besuyen, MD, L. Meuleners, MS, Galapagos NV, Mechelen, Belgium., Meuleners L; R. Besuyen, MD, L. Meuleners, MS, Galapagos NV, Mechelen, Belgium., Stanislavchuk M; M. Stanislavchuk, MD, National Pirogov Memorial Medical University, Vinnytsya, Ukraine., Spindler AJ; A.J. Spindler, MD, Centro Medico Privado de Reumatologia, San Miguel de Tucuman, Argentina., Greenwald M; M. Greenwald, MD, Desert Medical Advances, Palm Desert, California, USA., Alten R; R. Alten, MD, Schlosspark Klinik, University Medicine Berlin, Berlin, Germany., Genovese MC; M.C. Genovese, MD, Stanford University School of Medicine, Division of Immunology & Rheumatology, Stanford, and Gilead Sciences Inc., Foster City, California, USA.
Source: The Journal of rheumatology [J Rheumatol] 2021 Aug; Vol. 48 (8), pp. 1230-1238. Date of Electronic Publication: 2021 Feb 01.
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1499-2752 (Electronic) Linking ISSN: 0315162X NLM ISO Abbreviation: J Rheumatol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33526618
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kavanaugh+A%22">Kavanaugh A</searchLink>; A. Kavanaugh, MD, University of California San Diego, La Jolla, California, USA; akavanaugh@ucsd.edu.<br /><searchLink fieldCode="AU" term="%22Westhovens+RR%22">Westhovens RR</searchLink>; R.R. Westhovens, MD, PhD, KU Leuven, Skeletal Biology and Engineering Research Center, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Winthrop+KL%22">Winthrop KL</searchLink>; K.L. Winthrop, MD, MPH, Oregon Health and Science University, Portland, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Lee+SJ%22">Lee SJ</searchLink>; S.J. Lee, MD, Y. Tan, PhD, D. An, PhD, L. Ye, PhD, J.S. Sundy, MD, PhD, Gilead Sciences Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Tan+Y%22">Tan Y</searchLink>; S.J. Lee, MD, Y. Tan, PhD, D. An, PhD, L. Ye, PhD, J.S. Sundy, MD, PhD, Gilead Sciences Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22An+D%22">An D</searchLink>; S.J. Lee, MD, Y. Tan, PhD, D. An, PhD, L. Ye, PhD, J.S. Sundy, MD, PhD, Gilead Sciences Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Ye+L%22">Ye L</searchLink>; S.J. Lee, MD, Y. Tan, PhD, D. An, PhD, L. Ye, PhD, J.S. Sundy, MD, PhD, Gilead Sciences Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Sundy+JS%22">Sundy JS</searchLink>; S.J. Lee, MD, Y. Tan, PhD, D. An, PhD, L. Ye, PhD, J.S. Sundy, MD, PhD, Gilead Sciences Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Besuyen+R%22">Besuyen R</searchLink>; R. Besuyen, MD, L. Meuleners, MS, Galapagos NV, Mechelen, Belgium.<br /><searchLink fieldCode="AU" term="%22Meuleners+L%22">Meuleners L</searchLink>; R. Besuyen, MD, L. Meuleners, MS, Galapagos NV, Mechelen, Belgium.<br /><searchLink fieldCode="AU" term="%22Stanislavchuk+M%22">Stanislavchuk M</searchLink>; M. Stanislavchuk, MD, National Pirogov Memorial Medical University, Vinnytsya, Ukraine.<br /><searchLink fieldCode="AU" term="%22Spindler+AJ%22">Spindler AJ</searchLink>; A.J. Spindler, MD, Centro Medico Privado de Reumatologia, San Miguel de Tucuman, Argentina.<br /><searchLink fieldCode="AU" term="%22Greenwald+M%22">Greenwald M</searchLink>; M. Greenwald, MD, Desert Medical Advances, Palm Desert, California, USA.<br /><searchLink fieldCode="AU" term="%22Alten+R%22">Alten R</searchLink>; R. Alten, MD, Schlosspark Klinik, University Medicine Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Genovese+MC%22">Genovese MC</searchLink>; M.C. Genovese, MD, Stanford University School of Medicine, Division of Immunology & Rheumatology, Stanford, and Gilead Sciences Inc., Foster City, California, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227501984%22">The Journal of rheumatology</searchLink> [J Rheumatol] 2021 Aug; Vol. 48 (8), pp. 1230-1238. <i>Date of Electronic Publication: </i>2021 Feb 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Journal+Of+Rheumatology+Publishing+Co%22">Journal Of Rheumatology Publishing Co </searchLink><i>Country of Publication: </i>Canada <i>NLM ID: </i>7501984 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1499-2752 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220315162X%22">0315162X </searchLink><i>NLM ISO Abbreviation: </i>J Rheumatol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33526618
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3899/jrheum.201183
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1230
    Titles:
      – TitleFull: Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kavanaugh A
      – PersonEntity:
          Name:
            NameFull: Westhovens RR
      – PersonEntity:
          Name:
            NameFull: Winthrop KL
      – PersonEntity:
          Name:
            NameFull: Lee SJ
      – PersonEntity:
          Name:
            NameFull: Tan Y
      – PersonEntity:
          Name:
            NameFull: An D
      – PersonEntity:
          Name:
            NameFull: Ye L
      – PersonEntity:
          Name:
            NameFull: Sundy JS
      – PersonEntity:
          Name:
            NameFull: Besuyen R
      – PersonEntity:
          Name:
            NameFull: Meuleners L
      – PersonEntity:
          Name:
            NameFull: Stanislavchuk M
      – PersonEntity:
          Name:
            NameFull: Spindler AJ
      – PersonEntity:
          Name:
            NameFull: Greenwald M
      – PersonEntity:
          Name:
            NameFull: Alten R
      – PersonEntity:
          Name:
            NameFull: Genovese MC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2021 Aug
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1499-2752
          Numbering:
            – Type: volume
              Value: 48
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: The Journal of rheumatology
              Type: main
ResultId 1